瓣膜性心脏病患者接受非心脏手术的围术期管理
本文综述了显著瓣膜性心脏病(VHD)患者接受非心脏手术(NCS)的围术期管理策略。现有风险评分优先考虑手术风险和心血管危险因素,而忽视VHD的存在与程度。管理应聚焦VHD类型与严重程度、心室代偿机制及NCS风险;瓣膜干预推荐用于有症状或符合标准干预指征者,否则可在定制麻醉与有创血流动力学监测下手术,并建议术前心脏团队讨论。
要点
- 现有围术期风险评分未充分纳入VHD的存在与程度。
- 管理核心是VHD类型与严重度、心室代偿及NCS风险。
- 有症状或符合干预指征者建议NCS前瓣膜干预。
核心结论
- 显著VHD患者接受NCS时围术期不良心脏事件是重要问题,管理应基于VHD类型与严重程度、心室代偿机制及NCS风险个体化制定。
研究设计与样本
- 本文为综述,基于共识意见和大型观察性注册研究的推断,缺乏随机试验证据。
主要发现
- 推荐围术期风险评分优先考虑手术风险和心血管危险因素,而忽略VHD的存在与程度。
- 围术期管理和麻醉方法应聚焦VHD基础类型与严重程度、左右心室代偿机制以及NCS类型与风险。
关键数值与推荐
- 有症状或符合标准心脏干预指征的患者,推荐NCS前进行瓣膜干预。
- 无上述情况时,可在定制麻醉管理和密切有创围术期血流动力学监测下实施NCS。
临床怎么用
- 术前应与心脏团队讨论患者个体化管理策略。
- 有症状的重度VHD或接受高风险NCS者,理想情况下应在具备围术期血流动力学复杂患者管理能力的高容量医疗中心治疗。
局限性
- 缺乏随机试验研究NCS前不同瓣膜干预策略,推荐主要依赖共识意见和观察性注册研究推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In patients with significant valvular heart disease (VHD) undergoing non-cardiac surgery (NCS), perioperative adverse cardiac events are a relevant issue. Although postoperative outcomes can be adversely affected by valve-related haemodynamic instability, recommended perioperative risk scores prioritise the risk of the surgical procedure and the presence of cardiovascular risk factors, neglecting the presence or extent of VHD. Perioperative management and anaesthetic approach should focus on the underlying type and severity of VHD, the compensatory mechanisms deployed by left ventricle and right ventricle and the type and risk of NCS. Due to the lack of randomised trials investigating different therapeutic approaches of valvular intervention prior to NCS, recommendations mainly rely on consensus opinion and inference based on large observational registries. As a general rule, valvular intervention is recommended prior to NCS in symptomatic patients or in those who meet standard criteria for cardiac intervention. In the absence of such conditions, it is reasonable to perform NCS with tailored anaesthetic management and close invasive perioperative haemodynamic monitoring. However, patient-specific management strategies should be discussed with the heart team preoperatively. Symptomatic patients with severe VHD or those undergoing high-risk NCS should ideally be treated at a high-volume medical centre that is equipped to manage haemodynamically complex patients during the perioperative period.
引用
- Sorrentino R, Santoro C, Bardi L, et al. Non-cardiac surgery in patients with valvular heart disease. Heart. 2022. PMID: 34815334. doi:10.1136/heartjnl-2021-319160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。